Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis
- Conditions
- Chronic Bronchitis
- Interventions
- Device: Sham ProcedureDevice: RheOx Bronchial Rheoplasty
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Gala Therapeutics, Inc.
- Target Recruit Count
- 270
- Registration Number
- NCT04677465
- Locations
- 🇺🇸
Syed M. Alam, MD Pulmonology (Bakersfield Heart), Bakersfield, California, United States
🇺🇸University of Southern California, Los Angeles, California, United States
🇺🇸Emory University, Atlanta, Georgia, United States
RheOx Registry Study in Europe
- Conditions
- Chronic BronchitisCOPD
- Interventions
- Device: RheOx
- First Posted Date
- 2019-12-02
- Last Posted Date
- 2022-03-22
- Lead Sponsor
- Gala Therapeutics, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT04182841
- Locations
- 🇦🇹
Otto Wagner Spital, Wien, Austria
🇩🇪Pneumologie Thoraxklinik Heidelberg gGmbH University of Heidelberg, Heidelberg, Baden-Württemberg, Germany
Gala Early Feasibility Study of RheOx
- Conditions
- Chronic BronchitisCopd Bronchitis
- Interventions
- Device: RheOx
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2022-05-09
- Lead Sponsor
- Gala Therapeutics, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT03631472
- Locations
- 🇺🇸
University of Alabama Lung Health Center, Birmingham, Alabama, United States
🇺🇸Mayo Clinic Florida, Jacksonville, Florida, United States
🇺🇸University of Iowa, Iowa City, Iowa, United States
Gala Treatment for Chronic Bronchitis in Canada
- Conditions
- Chronic BronchitisCOPD
- Interventions
- Device: Gala Airway Treatment System
- First Posted Date
- 2017-12-28
- Last Posted Date
- 2021-08-04
- Lead Sponsor
- Gala Therapeutics, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT03385616
- Locations
- 🇨🇦
IUCPQ Quebec, Quebec, Canada
🇨🇦Notre Dame Hospital at CHUM, Montreal, Canada
🇨🇦St. Paul's Hospital Vancouver Centre for Heart Lung Innovation, Vancouver, British Columbia, Canada
Gala FIH Feasibility Study for the Treatment of Chronic Bronchitis
- Conditions
- Chronic Bronchitis
- Interventions
- Device: Gala Airway Treatment System
- First Posted Date
- 2017-04-11
- Last Posted Date
- 2020-09-01
- Lead Sponsor
- Gala Therapeutics, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT03107494
- Locations
- 🇦🇹
Otto Wagner Spital, Wien, Austria
🇨🇱Clinica Alemana, Santiago, Chile